Prescription Drug Rebates News and Resources for Healthcare

How Do Rebates Impact Part D Spending for Plans, Beneficiaries?

September 11, 2023 - While rebates may lower Medicare Part D spending for plan sponsors, they do not reduce drug costs for Medicare beneficiaries, a study conducted by the US Government Accountability Office (GAO) found. Medicare Part D drug spending surpassed $200 billion in 2021, according to GAO. Part D plan sponsors can negotiate rebates with drug manufacturers who...

Inflationary Rebates for Generic Drugs Offset Medicaid Spending

June 14, 2023 by Victoria Bailey

Inflationary rebates for generic drugs helped offset Medicaid spending from 2017 to 2020, but additional policies are needed to improve generic competition, according to a study published in Health...

CMS Proposed Rule Addresses Drug Cost Transparency in Medicaid

May 24, 2023 by Victoria Bailey

The Centers for Medicare and Medicaid Services (CMS) has issued a proposed rule that aims to increase the transparency of prescription drug costs in Medicaid. “This proposed rule prioritizes...

Payers, Orgs React to Coverage Implications of Build Back Better

November 22, 2021 by Kelsey Waddill

Updated 11/22/21: This article has been updated to include a statement from AHIP. Payers and stakeholder organizations have had mixed reactions to the Build Back Better Act, which passed in the...

AHIP, ACAP Call for Reversals on Prior Administration’s Policies

February 04, 2021 by Kelsey Waddill

Major payer organizations, specifically America’s Health Insurance Plans (AHIP) and the Association for Community Health Plans (ACAP), are calling for a reversal on key Trump healthcare...

What the New Rebate Rule Means for Medicare Part D Plans, MCOs

November 23, 2020 by Kelsey Waddill

The Department of Health and Human Services has released its finalized rebate rule which changes safe harbors around prescription drug pricing, impacting Medicare Part D plans and certain Medicaid...